NCT03786770View on ClinicalTrials.gov

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

March 9, 2020

Study Completion Date

March 9, 2020

Conditions
Frown Lines
Interventions
BIOLOGICAL

DaxibotulinumtoxinA for injection

Intramuscular injection

Trial Locations (4)

33146

Coral Gables site, Coral Gables

33431

Boca Raton site, Boca Raton

M5R3N8

Toronto, Ontario site, Toronto

L4L8E2

Woodbridge, Ontario site, Woodbridge

All Listed Sponsors
lead

Revance Therapeutics, Inc.

INDUSTRY

NCT03786770 - Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) | Biotech Hunter | Biotech Hunter